18 research outputs found
Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes
Epstein Barr virus (EBV) is a gamma herpes virus associated with certain malignancies and autoimmune diseases. EBV maintains latency in B cells with occasional reactivation, in part by overcoming the host immune response with viral homologs of several human proteins. EBV interleukin 10 (vIL-10), a lytic phase protein, is a homolog of human IL-10 (hIL-10). The effect of vIL-10 on human monocytes, which are one of the first immune cells to respond to infection, is not known. To understand the role of vIL-10, monocytes from peripheral blood mononuclear cells were stimulated with hIL-10 or vIL-10. Human IL-10 stimulated STAT3 phosphorylation, which is required for suppression of inflammatory responses. However, vIL-10 induced significantly lower phosphorylation of STAT3 compared to hIL-10, and was less efficient in downregulating inflammatory genes. vIL-10 significantly reduced the expression of scavenger receptor CD163 on monocytes, suggesting inhibition of M2 polarization. Furthermore, uptake of apoptotic cells was reduced in vIL-10-stimulated monocytes compared to hIL-10-stimulated monocytes. A neutralizing antibody to IL-10R1 inhibited STAT3 phosphorylation induced by either hIL-10 or vIL-10, suggesting that vIL-10 signals through IL-10R1. Interestingly, vIL-10 suppressed hIL-10-induced STAT3 phosphorylation and inhibited upregulation of suppressors of inflammatory response by hIL-10. We further show that vIL-10 levels were significantly higher in plasma samples from systemic lupus erythematosus (SLE) patients compared to matched unaffected controls. vIL-10 levels did not correlate with hIL-10 levels, but were associated with levels of IgA antibodies to EBV viral capsid antigen, which is an indirect measure of viral reactivation. We propose that the suppression of hIL-10- induced anti-inflammatory genes by vIL-10, together with an increase in inflammatory gene expression, may overcome the anti-inflammatory effects of hIL-10 and exacerbate autoimmune responses in systemic autoimmune diseases
Neutrophils isolated from systemic lupus erythematosus patients exhibit a distinct functional phenotype
Neutrophil dysregulation, particularly of a low-density subset, is associated with systemic lupus erythematosus (SLE); however, the exact role of normal-density neutrophils in SLE remains unknown. This study compares activation and functional phenotypes of neutrophils from SLE patients and healthy controls to determine potential contributions to SLE pathogenesis. Surface activation markers and release of neutrophil extracellular traps (NETs), granule proteins, and cytokines/chemokines were measured in resting and stimulated neutrophils from SLE patients (n=19) and healthy controls (n=10). Select miRNA and mRNA involved in neutrophil development and function were also measured. Resting SLE neutrophils exhibited fewer activation markers compared to control neutrophils, and activation markers were associated with different plasma cytokines/chemokines in SLE patients compared to healthy controls. However, activation markers increased similarly in SLE and control neutrophils following stimulation with a TLR7/8 agonist, neutrophil growth factors, and bacterial mimic. At the resting state, SLE neutrophils produced significantly more CXCL10 (IP-10), with trends toward other increased cytokines/chemokines. Following stimulation, SLE neutrophils produced fewer NETs and proinflammatory cytokines compared to control neutrophils but more MMP-8. In addition, SLE neutrophils expressed less miR130a, miR132, miR27a, and miR223. In conclusion, SLE neutrophils exhibit distinct functional responses compared to control neutrophils. These functional differences may result from differential gene expression via miRNAs. Furthermore, the differences in functional phenotype of SLE neutrophils suggest that they may contribute to SLE differently dependent on the inflammatory milieu
Heat Shock Protein 27 Regulates Neutrophil Chemotaxis and Exocytosis through Two Independent Mechanisms
Counterregulation of clathrin-mediated endocytosis by the actin and microtubular cytoskeleton in human neutrophils
Immune-Mediated Nephropathy and Systemic Autoimmunity in Mice Does Not Require Receptor Interacting Protein Kinase 3 (RIPK3)
<div><p>Immune mediated nephropathy is one of the most serious manifestations of lupus and is characterized by severe inflammation and necrosis that, if untreated, eventually leads to renal failure. Although lupus has a higher incidence in women, both sexes can develop lupus glomerulonephritis; nephritis in men develops earlier and is more severe than in women. It is therefore important to understand the cellular and molecular mechanisms mediating nephritis in each sex. Previous work by our lab found that the absence or pharmacological inhibition of Poly [ADP-ribose] polymerase 1 (PARP-1), an enzyme involved in DNA repair and necrotic cell death, affects only male mice and results in milder nephritis, with less in situ inflammation, and diminished incidence of necrotic lesions, allowing for higher survival rates. A second pathway mediating necrosis involves Receptor-Interacting Serine-Threonine Kinase 3 (RIPK3); in this study we sought to investigate the impact of RIPK3 on the development of lupus and nephritis in both sexes. To this end, we used two inducible murine models of lupus: chronic graft versus host disease (cGvHD) and pristane-induced lupus; and nephrotoxic serum (NTS)-induced nephritis as a model of immune mediated nephropathy. We found that the absence of RIPK3 has neither positive nor negative impact on the disease development or progression of lupus and nephritis in all three models, and in both male and female mice. We conclude that RIPK3 is dispensable for the pathogenesis of lupus and immune mediated nephropathy as to accelerate, worsen or ameliorate the disease.</p></div
Pristane-induced systemic autoimmunity is not dependent on RIPK3.
<p><i>(A)</i> Pristane treatment induced similar ANA patterns between WT and RIPK3-/- mice. Experiments were performed with 14 mice per strain, p>0.05 using Chi Square analysis. <i>(B)</i> After 6 months and <i>(C)</i> after 2 weeks from pristane injection, peritoneal immune cell infiltrates were characterized by flow cytometry. There were similar percentages of B cells, T cells, CD11b+ monocytes, and CD11b+/CD11c+ conventional dendritic cells (cDCs) present in the peritoneal cavity during pristine-induced systemic autoimmunity. 5 mice per strain were used for the acute, 14 mice per strain were used for the chronic (6 month) experiments. Data are represented by ± SEM and population differences (p>0.05) measured using Ttest.</p
Absence of RIPK3 does not ameliorate NTS-induced nephritis in males or females.
<p>Male and female B6 and RIPK3 mice were injected i.p. with 8ul/g NTS. <i>(A)</i> BUN levels were measured using Azostix throughout the experiment to monitor kidney disease. Male and female mice lacking RIPK3 did not have significantly decreased renal damage with NTS treatment. The data shown have 5–8 (pooled experiments) mice and p>0.05 as measured by Wilcoxon-Rank Sum analysis. <i>(B)</i> Kidney sections from NTS-treated and control mice were stained to detect IgG and C3 deposition. (C) Kidneys from the NTS-treated mice were sectioned and stained with H&E (size bars = 200um). The sections were scored for severity of glomerulonephritis, interstitial nephritis, and vessel damage. N = 5–8 mice per strain and significance was, measured by Mann-Whitney U test, * = p ≥ 0.05. Representative images for histology grading (10x magnification) are located below the scoring graphs. Data shown are pooled from three sets of experiments, except the RIP3-/-PARP1-/- experiments which were two sets. Data represented as Mean ± SD.</p
Absence of RIPK3 does not affect the development of autoimmunity induced by cGvHD or pristane.
<p><i>(A)</i> After induction of cGvHD, anti-dsDNA and anti-chromatin levels were similar between B6 and RIPK3-/- mice in both males and females. Data are represented as Mean ± SEM of 10 mice per group (pooled from two experiments) and all p-values were >0.05 (T-test). Autoantibody levels of PBS-treated mice are represented by the dotted line. <i>(B)</i> After cGVHD induction, total IgG levels were similar between B6 and RIPK3-/- mice in both males and females. Data are represented as Mean ± SEM of 10 mice per group and all p-values were >0.05 (T-test). Total IgG levels were increased at 3 and 6 weeks compared to pre-bleed (T-test). Pre-bleed vs. 3 weeks: * p≤0.05, ** p≤ 0.01. Pre-bleed vs. 6 weeks: # p≤0.05.</p
Absence of RIPK3 does not cause a reduction in necrotic cell death within the kidney during NTS-nephritis.
<p>Percentage of apoptotic and necrotic TUNEL+ cells were determined by staining for TUNEL (red), active Caspase 3 (green), and nuclei (DAPI-blue). 10x size bar = 200μm, 40x size bar = 50μm. At least 50 TUNEL+ cells were recorded for each mouse, N = 5 mice per strain. Necrotic nuclei were characterized by only TUNEL+ staining, while apoptotic cells were positive for both TUNEL and active-caspase 3. Percentages of positive cells between B6 and RIPK3-/-, in each sex were not statistically significant (p≥0.05) as determined by T-test. Data is represented as Mean ± SEM of 2–5 mice per group. Experiments were repeated at least twice.</p